Study Explores Drug Treatments for Early-onset Alzheimer’s disease
A recent clinical trial, funded in part by NIA, explored the impact of two drugs, gantenerumab or solanezumab, on symptoms and Alzheimer’s disease biomarkers among people with a rare type of early-onset dementia caused by genetic mutations. Researchers conducting the study enrolled participants who had inherited these mutations. Some of the participants had mild symptoms of …
Study Explores Drug Treatments for Early-onset Alzheimer’s disease Read More »